IGC Pharma Inc.
Organization details
- Legal name
- IGC Pharma Inc.
- Former names
- India Globalization Capital, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Maryland
- Headquarters city
- Potomac
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IGC
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001326205
- EIN
- 20-2760393
Board of directors
-
Claudia Grimaldi · Director · PFOSince 2024
-
James P. Moran · DirectorSince 2023
-
Ram Mukunda · Director · CEOSince 2023
-
Richard K. Prins · DirectorSince 2023
-
Terry L. Lierman · DirectorSince 2024
Chief executives
Director election results
Annual meeting of October 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.3%
-
98.5%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Amphastar Pharmaceuticals Inc. Same sectorvia Richard K. Prins
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 25, 2026 | Claudia Grimaldi Director, Officer (PFO) | Gift | −150,000 | — | — |
| Sep 25, 2026 | Ram Mukunda Director, Officer (CEO) | Gift | −100,000 | — | — |
| Sep 25, 2026 | Ram Mukunda Director, Officer (CEO) | Gift | −100,000 | — | — |
| Jun 30, 2026 | Claudia Grimaldi Director, Officer (PFO) | Grant or award | +2,048,378 | $0.27 | $553,062 |
| Jun 30, 2026 | Ram Mukunda Director, Officer (CEO) | Grant or award | +2,226,475 | $0.27 | $601,148 |
| Apr 1, 2026 | Richard K. Prins Director | Option exercise | +100,000 | — | — |
| Apr 1, 2026 | Ram Mukunda Director, Officer (CEO) | Option exercise | +333,333 | — | — |
| Apr 1, 2026 | James P. Moran Director | Option exercise | +80,000 | — | — |
| Apr 1, 2026 | Claudia Grimaldi Director, Officer (PFO) | Option exercise | +100,000 | — | — |
| Apr 1, 2026 | Richard K. Prins Director | Option exercise | +70,000 | — | — |
| Apr 1, 2026 | Ram Mukunda Director, Officer (CEO) | Option exercise | +323,077 | $0.26 | $84,000 |
| Apr 1, 2026 | James P. Moran Director | Option exercise | +50,000 | — | — |
| Apr 1, 2026 | Claudia Grimaldi Director, Officer (PFO) | Option exercise | +138,462 | $0.26 | $36,000 |
| Apr 1, 2026 | Ram Mukunda Director, Officer (CEO) | Option exercise | +16,667 | — | — |
| Apr 1, 2026 | Ram Mukunda Director, Officer (CEO) | Option exercise | +33,332 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about IGC Pharma Inc.
Who is the CEO of IGC Pharma Inc.?
Ram Mukunda is IGC Pharma Inc.'s CEO.
How many directors are on IGC Pharma Inc.'s board?
IGC Pharma Inc.'s board has 5 directors: Claudia Grimaldi, James P. Moran, Ram Mukunda, Richard K. Prins and Terry L. Lierman.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="igc-pharma-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.